The acknowledgement of cardiovascular disease as one of the leading causes of mortality and morbidity among cancer survivors is the cornerstone of the growing

 

Abstract

The acknowledgement of cardiovascular disease as one of the leading causes of mortality and morbidity among cancer survivors is the cornerstone of the growing field of cardio-oncology. Although standardizing treatment for any given disease is often considered ideal, it is important to recognize the value of pursuing a practical and personalized approach when caring for an oncology patient to minimize the risk of treatment-related cardiotoxicity. We hereby discuss a series of cases that illustrate the ways vascular toxicity can manifest in patients with cancer and, when appropriate, provide scientific evidence that supports clinical decision making. We also raise questions about the complex management of these patients while shedding light on future research in this growing field.

PMID: 31988690 [PubMed - in process]

16:00

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

16:00

In reply to this message

pubmed: ctoall&ca or conall

Electrophysiologic Complications in Cancer Patients.

Related Articles

Electrophysiologic Complications in Cancer Patients.

Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):282-288

Authors: Lee DH, Chandrashekhar S, Fradley MG

Abstract

In recent years, dramatic advances in both cancer diagnosis and treatment have led to significantly increased survival rates. As such, cardiovascular toxicities due to oncologic treatments are more frequently identified. Although heart failure and cardiomyopathy have historically been the cardiotoxicities most associated with cancer therapeutics, it is now recognized that all components of the cardiovascular system can be affected. In this review, we discuss electrophysiologic complications of cancer treatments, including atrial and ventricular tachyarrhythmias as well as bradyarrhythmias, and recommend a multidisciplinary approach with both cardiologists and oncologists to provide safe and effective care to these patients.

PMID: 31988689 [PubMed - in process]

16:00

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

16:00

In reply to this message

pubmed: ctoall&ca or conall

Cardiovascular Toxicities of Radiation Therapy.

Related Articles

Cardiovascular Toxicities of Radiation Therapy.

Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):274-281

Authors: Lewis GD, Farach A